Raymond James Financial’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-9,153
Closed -$162K 5210
2025
Q2
$162K Buy
+9,153
New +$178K ﹤0.01% 4618
2025
Q1
Sell
-10,595
Closed -$196K 4830
2024
Q4
$196K Buy
+10,595
New +$204K ﹤0.01% 4410

Other funds holding BTAL

Raymond James Financial's BTAL Position: Q3 2025 in Review

Raymond James Financial sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2025, closing a stake of 9,153 shares — an estimated $162K sold.

Raymond James Financial first reported a position in BTAL in Q4 2024 and held it in 2 quarters. The position peaked at $196K in Q4 2024. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2025.

  • Raymond James Financial reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 9,153 AGF US Market Neutral Anti-Beta Fund shares in Q3 2025, an estimated $162K.
  • Raymond James Financial first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2024 and held it in 2 quarters.
  • Raymond James Financial's AGF US Market Neutral Anti-Beta Fund position peaked at $196K in Q4 2024.
  • 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.